BCM
ARRY

Bluefin Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Bluefin Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-263,043
Closed -$1.2M – 805
2015
Q3 		$1.2M Buy
263,043
+134,131
+104% +$795K 0.07% 171
2015
Q2 		$929K Buy
+128,912
New +$951K 0.06% 226

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bluefin Capital Management's ARRY Position: Q4 2015 in Review

Bluefin Capital Management sold out of Array Biopharma Inc (ARRY) in Q4 2015, closing a stake of 263,043 shares — an estimated $1.2M sold.

Bluefin Capital Management first reported a position in ARRY in Q2 2015 and held it in 2 quarters. The position peaked at $1.2M in Q3 2015. 151 funds tracked by Wall St. Rank hold ARRY as of Q4 2015.

  • Bluefin Capital Management reported no remaining Array Biopharma Inc position as of Q4 2015 after selling out during the quarter.
  • Bluefin Capital Management sold 263,043 Array Biopharma Inc shares in Q4 2015, an estimated $1.2M.
  • Bluefin Capital Management first reported a position in Array Biopharma Inc in Q2 2015 and held it in 2 quarters.
  • Bluefin Capital Management's Array Biopharma Inc position peaked at $1.2M in Q3 2015.
  • 151 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2015.

Based on Bluefin Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.